| |
| |
|
| Insider
Information: |
Secor Alicia |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
20,000 |
|
|
Indirect Shares
|
4,000 |
|
|
| Direct
Value |
$79,800 |
|
|
|
Indirect Value
|
$4,600 |
|
|
| Total
Shares |
24,000 |
|
|
| Total
Value |
$84,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 19.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Larimar Therapeutics Inc |
LRMR |
Chief Commercial Officer |
2015-09-17 |
0 |
2015-09-17 |
4,000 |
Premium* |
|
|
Juniper Pharmaceuticals Inc |
JNP |
President and CEO, Dir... |
2018-08-14 |
0 |
2016-08-25 |
0 |
Premium* |
|
|
Gw Pharmaceuticals Plc |
GWPH |
Director |
2021-05-05 |
0 |
2019-01-03 |
0 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
|
2023-06-15 |
20,000 |
2022-06-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Director |
– • – |
2021-05-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,584) |
0 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Director |
– • – |
2021-03-01 |
4 |
D |
$17.85 |
$22,491 |
D/D |
(1,260) |
10,584 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Director |
– • – |
2021-03-01 |
4 |
OE |
$0.00 |
$4 |
D/D |
3,144 |
11,844 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Director |
– • – |
2021-01-04 |
4 |
OE |
$0.00 |
$5 |
D/D |
3,576 |
10,140 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Director |
– • – |
2021-01-04 |
4 |
D |
$9.62 |
$13,853 |
D/D |
(1,440) |
8,700 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Director |
– • – |
2020-03-02 |
4 |
S |
$8.34 |
$10,809 |
D/D |
(1,296) |
16,440 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Director |
– • – |
2020-01-03 |
4 |
S |
$8.53 |
$13,102 |
D/D |
(1,536) |
17,736 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Director |
– • – |
2019-03-13 |
4 |
S |
$14.20 |
$12,780 |
D/D |
(900) |
19,272 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Director |
– • – |
2019-01-03 |
4 |
OE |
$0.00 |
$5 |
D/D |
3,580 |
20,172 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
President and CEO |
• • – |
2018-08-14 |
4 |
D |
$11.50 |
$1,194,333 |
D/D |
(103,855) |
0 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
President and CEO |
• • – |
2018-03-03 |
4 |
D |
$8.80 |
$16,456 |
D/D |
(1,870) |
86,355 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
President and CEO |
• • – |
2018-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
50,500 |
88,225 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
President and CEO |
• • – |
2018-02-07 |
4 |
D |
$8.40 |
$29,190 |
D/D |
(3,475) |
37,725 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
President and CEO |
• • – |
2018-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
41,200 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
President and CEO |
• • – |
2017-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
26,200 |
31,200 |
0 |
- |
|
| JNP |
Juniper Pharmaceuticals I... |
President and CEO |
• • – |
2016-08-25 |
4 |
B |
$5.75 |
$28,750 |
D/D |
5,000 |
5,000 |
2.81 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Commercial Officer |
• – – |
2015-09-17 |
4 |
AS |
$41.05 |
$1,077,809 |
D/D |
(26,256) |
0 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Commercial Officer |
• – – |
2015-09-17 |
4 |
OE |
$9.67 |
$241,750 |
D/D |
25,000 |
26,256 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Commercial Officer |
• – – |
2014-06-19 |
4 |
B |
$20.00 |
$80,000 |
I/I |
4,000 |
4,000 |
1.99 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
